Guangzhou Kingmed Diagnostics Group Co., Ltd.

Shanghai Stock Exchange 603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd. Net Income Margin for the year ending December 31, 2023: 7.53%

Guangzhou Kingmed Diagnostics Group Co., Ltd. Net Income Margin is 7.53% for the year ending December 31, 2023, a -57.67% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Guangzhou Kingmed Diagnostics Group Co., Ltd. Net Income Margin for the year ending December 31, 2022 was 17.80%, a -4.22% change year over year.
Guangzhou Kingmed Diagnostics Group Co., Ltd. Net Income Margin for the year ending December 31, 2021 was 18.58%, a 1.48% change year over year.
Guangzhou Kingmed Diagnostics Group Co., Ltd. Net Income Margin for the year ending December 31, 2020 was 18.31%, a 139.85% change year over year.
Guangzhou Kingmed Diagnostics Group Co., Ltd. Net Income Margin for the year ending December 31, 2019 was 7.64%, a 48.09% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

Shanghai Stock Exchange: 603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

CEO	Mr. Yaoming Liang
IPO Date	Sept. 8, 2017
Location	China
Headquarters	No. 10, Helix 3rd Road
Employees	11,586
Sector	Health Care
Industries Medical Instruments Biotechnology Hospitals & Clinics Pharmaceuticals

Description

Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a third-party medical laboratory company. The company offers medical diagnostic information, clinical trial, lab, food and hygiene testing, health management, medical cold chain logistics, and scientific research services, as well as vitro diagnostics, healthcare big data, artificial intelligence, and forensic testing services. It operates 37 testing laboratories in mainland of China and Hong Kong. The company was founded in 2003 and is headquartered in Guangzhou, China.

Key trends

Past 5 years